Dr. Jennifer Spencer received her PhD in Health Policy and Management in 2019 from the University of North Carolina at Chapel Hill. Her research focuses on applying econometric and decision science methods to understand inequities in cancer care and identify effective strategies for improving care access and quality- especially for traditionally underserved groups.
Dr. Spencer is a postdoctoral fellow in the Dana Farber Cancer Institute’s Training in Oncology Population Sciences (TOPS) Fellowship Program under the mentorship of Dr. Jane Kim. Her current work focuses on equity in HPV modeling, particularly the incorporation of sexual minority men into HPV transmission and vaccination models. She is a member of the Sexual Orientation and Gender Identity and Expression (SOGIE) Health Research Collaborative and the President of the Harvard TH Chan Postdoctoral Association.
During her time at UNC-Chapel Hill, Dr. Spencer was a predoctoral fellow in the Cancer Care Quality Training Program (CCQTP). Her dissertation, HPV Vaccination as a Mechanism to Reduce Socioeconomic Disparities in Cancer Prevention explored current and future disparities in HPV cancers by county poverty and identified cost-effective strategies for increasing HPV vaccine uptake. This work was award the Marci B. Campbell Dissertation Award for excellence in cancer population sciences from the Lineberger Comprehensive Cancer Center.
Dr. Spencer has a background in improvisational theater and is interested in innovative and engaging approaches to teaching and research communication. She was a finalist in UNC-Chapel Hill’s Three Minute Thesis competition, a finalist in AcademyHealth’s Presenting Research in Compelling Ways student competition, and won Best Oral Presentation at the Dana Farber/Harvard Cancer Center’s Celebration of Early Career Researchers. She is interested in effective research dissemination, including interactive data visualization and video abstracts.
- Health equity, health care access
- Decision science, simulation modeling methods, cost effectiveness
- Cancer prevention, cancer screening, HPV vaccination
Spencer JC, Brewer NT, Trogdon JT, et al. Cost Effectiveness of Interventions to Increase HPV Vaccine Uptake. Pediatrics. 2020. Epub ahead of press.
Spencer JC, Calo WA, Brewer NT. Disparities and reverse disparities in HPV vaccination: A systematic review and meta-analysis. Prev Med. 2019. doi:10.1016/j.ypmed.2019.03.037
Spencer JC, Rotter JS, Eberth JM, et al. Employment Changes Following Breast Cancer Diagnosis: The Effects of Race and Place. J Natl Cancer Inst. 2020. doi:10.1093/jnci/djz197
Spencer JC, Wheeler SB, Rotter JS, Holmes GM. Decomposing Mortality Disparities in Urban and Rural U.S. Counties. Health Serv Res. 2018;53(6):4310-4331. doi:10.1111/1475-6773.12982
Spencer JC, Brewer NT, Trogdon JG, Wheeler SB, Dusetzina SB. Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients. Am J Public Health. 2018;108(7):946-950. doi:10.2105/AJPH.2018.304408
Spencer JC, Louie M, Moulder JK, et al. Cost-effectiveness of treatments for heavy menstrual bleeding. Am J Obstet Gynecol. 2017;217(5):574.e1-574.e9. doi:10.1016/J.AJOG.2017.07.024
See all publications on GoogleScholar.